Release Date: 30/05/11 08:45 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 22.41KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%